DCTH Stock Analysis: Buy, Sell, or Hold?
DCTH - Delcath Systems Inc
$12.94
0.62 (5.03%)
▲
5d:
+10.69%
30d:
+18.61%
90d:
+41.73%
HOLD
MODERATE Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When DCTH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: DCTH is 7.9% above its trading range ($11.99). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: DCTH is 7.9% above its trading range ($11.99). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: DCTH is currently trading at $12.94, which is considered extended relative to its 30-day fair value range of $10.72 to $11.99. From a valuation perspective, the stock is trading at a discount (Forward PE: -25.4) compared to its historical average (48.5). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, DCTH is in a uptrend. The price is approaching resistance at $12.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: DCTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.35 (+65.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DCTH is in a uptrend. The price is approaching resistance at $12.17. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 5.0% recently.
Market Sentiment: DCTH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.35 (+65.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.72 -
$11.99
Company Quality Score
59/100
(HOLD)
Options IV Signal
67th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
63.5%
All Signals
- BEARISH: Price extended above range (+7.9% above its trading range)
- NEUTRAL: Options fairly priced (IV 67th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.0%)
- BULLISH: Trading 65.0% below Wall St target ($21.35)
- CAUTION: Extended 7.9% above its trading range - wait for pullback
Trading Range Analysis
30-Day Trading Range
$10.72 -
$11.99
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.09
(16.2%)
Support & Resistance Levels
Support Level
$10.20
Resistance Level
$12.17
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-25.37
Wall Street Target
$21.35
(+65.0%)
Revenue Growth (YoY)
26.3%
Earnings Growth (YoY)
-66.7%
Profit Margin
0.6%
PE vs Historical
-25.4 vs 48.5
CHEAP
Share & Embed Analysis
Last updated: June 27, 2026 2:56 PM ET
Data refreshes hourly during market hours. Next update: 3:56 PM
Data refreshes hourly during market hours. Next update: 3:56 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DCTH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 55 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 68 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 64 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 61 BUY |
